Dr. Reynolds Delgado works in Houston, TX as a Cardiologist and is a leader in the field of heart failure.  He is a member of Texas Heart Institute and is on staff at Baylor St. Luke’s Medical Center. 

Dr. Delgado is board certified in Advanced Heart Failure and Transplant Cardiology and graduated from University of Texas Southwestern Medical Center.  He completed residency at University of Texas Southwestern Medical Center and fellowship at Texas Heart Institute. 

Dr. Delgado is a Medical Director of Mechanical Support Devices in Heart Failure at Texas Heart Institute and has been on various advisory boards as well as being principal investigator on several clinical studies.  In addition, he has authored articles in the New England Journal of Medicine that led to FDA approval of the Heartmate II™ LVAD.

In addition to being a Founder and board member of Anaxiom, Dr. Delgado is a co-founder and President of the Houston Heart Failure Society and a long-standing research collaborator with NASA Johnson Space Center’s human space flight physiology laboratory.  He is also the founder of Procyrion, Inc.